TO THE EDITOR—We read with interest the recent article by Thibault et al [1], which described laboratory analyses of injection equipment collected from people who inject drugs in France. In particular, the detection of hepatitis C virus (HCV) RNA in 80% of pooled samples of alcohol and cotton swabs raises concerns about the possible role of swabs in HCV transmission. While the accompanying edit...

BACKGROUND The ability to self-inject in patients with multiple sclerosis (MS) has been associated with a reduced risk of missed injections and drug discontinuation, and a beneficial effect on patients' independence. However, injection anxiety, needle phobia and disease-related disability are major barriers to a patient's ability to self-administer treatment. Use of an autoinjector may improve ...

BACKGROUND Of the nearly 100,000 street-based IDUs in Pakistan, 20% have HIV. We investigated the recent rise in HIV prevalence from 12 to 52% among IDUs in Sargodha despite > 70% coverage with syringe exchanges. METHODS We interviewed approximately 150 IDUs and 30 outreach workers in focus group discussions. RESULTS We found six rural and 28 urban injecting locations. Urban locations have ...

www.ondrugdelivery.com 27 In this article, Mahesh Chaubal, PhD, Senior Director, Drug Development, R&D Medical Products, Baxter Healthcare Corporation, provides a glimpse of some of the challenges faced during the development of viscous formulations of biopharmaceutical products for injection, from a formulator’s perspective, especially when the finished product is filled in a prefilled syringe...

New flow techniques such as multicommutated flow-injection analysis (MCFIA), multi-syringe FIA (MSFIA) and multi-pumping flow systems (MPFSs) have been developed. The low reagent consumption achieved by these techniques should be highlighted, as they can be regarded as environmentally friendly alternatives to conventional FIA. We present several applications of these novel flow techniques to th...

The front chamber of LUPRON DEPOT 3.75 mg prefilled dual-chamber syringe contains leuprolide acetate (3.75 mg), purified gelatin (0.65 mg), DL-lactic and glycolic acids copolymer (33.1 mg), and D-mannitol (6.6 mg). The second chamber of diluent contains carboxymethylcellulose sodium (5 mg), D-mannitol (50 mg), polysorbate 80 (1 mg), water for injection, USP, and glacial acetic acid, USP to cont...